Christopher Moller
Directeur/Membre du Conseil chez PharmaStem Therapeutics, Inc.
Profil
Christopher Moller is currently a Director at PharmaStem Therapeutics, Inc. and Devon Park Associates LLC.
He previously worked as a Director at QuatRx Pharmaceuticals Co., Sopherion Therapeutics LLC, and CombinatoRx, Inc. He was also a Managing Director at TL Ventures, Inc. from 1992 to 2008.
From 2008 to 2014, he served as an Independent Director at CARA Therapeutics, Inc. He has also been a Director at Genomics Collaborative, Inc. and Vascular Magnetics, Inc. Additionally, he was a General Partner at Devon Park Bioventures.
Moller received his undergraduate degree from Pomona College in 1986 and his doctorate from the University of Pennsylvania in the same year.
Postes actifs de Christopher Moller
| Sociétés | Poste | Début |
|---|---|---|
PharmaStem Therapeutics, Inc.
 PharmaStem Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PharmaStem Therapeutics, Inc. develops umbilical cord and placental blood preservation drugs. The company was founded in 1985 and is headquartered in Larchmont, NY. | Directeur/Membre du Conseil | - |
| Devon Park Associates LLC | Directeur/Membre du Conseil | - |
Anciens postes connus de Christopher Moller
| Sociétés | Poste | Fin |
|---|---|---|
| CARA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 16/07/2014 |
TL Ventures, Inc.
 TL Ventures, Inc. Investment ManagersFinance TL Ventures Inc (TL Ventures) is a venture capital subsidiary of Safeguard Scientifics, Inc. founded in 1988 by Robert Keith. The firm is headquartered in Wayne, Pennsylvania. | Private Equity Investor | 30/04/2008 |
CombinatoRx, Inc.
 CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | Directeur/Membre du Conseil | 20/02/2006 |
Vascular Magnetics, Inc.
 Vascular Magnetics, Inc. Medical DistributorsDistribution Services Vascular Magnetics, Inc. develops novel therapeutic products. Its VMI contains a magnetic targeting catheter, an apparatus that generates a uniform magnetic field around the leg, and biodegradable magnetic particles that contain a drug that blocks re-obstruction of the artery. The company was founded by Richard S. Woodward and Robert J. Levy in 2010 and is headquartered in Philadelphia, PA. | Directeur/Membre du Conseil | - |
Devon Park Bioventures
 Devon Park Bioventures Investment ManagersFinance Devon Park Bioventures (Devon Park Bioventures) is a venture capital firm founded in 2006. The firm is headquartered in Pennsylvania, United States. | President | - |
Formation de Christopher Moller
| Pomona College | Undergraduate Degree |
| University of Pennsylvania | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| CARA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 9 |
|---|---|
QuatRx Pharmaceuticals Co.
 QuatRx Pharmaceuticals Co. Pharmaceuticals: MajorHealth Technology QuatRx Pharmaceuticals Co. manufactures and develops therapeutic compounds. Its clinical products, ospemifene and fispemifene, treat hormone deficiencies that result from aging in women and men. The firm's preclinical program is designed to address sex steroid dependent diseases through inhibition of 17beta- hydroxysteroid dehydrogenase (HSD) enzymes. The company was founded by Robert Zerbe, Christopher Nicholas, and Stuart Dombey on November 20 2000 and is headquartered in Ann Arbor, MI. | Health Technology |
TL Ventures, Inc.
TL Ventures, Inc. Investment ManagersFinance TL Ventures Inc (TL Ventures) is a venture capital subsidiary of Safeguard Scientifics, Inc. founded in 1988 by Robert Keith. The firm is headquartered in Wayne, Pennsylvania. | Finance |
Sopherion Therapeutics LLC
 Sopherion Therapeutics LLC BiotechnologyHealth Technology Sopherion Therapeutics LLC develops and commercializes anti-cancer therapies. The company was founded by Ronald H. Goldfarb and Salvatore Forenza in 2002 and is headquartered in Princeton, NJ. | Health Technology |
CombinatoRx, Inc.
CombinatoRx, Inc. Pharmaceuticals: OtherHealth Technology CombinatoRx, Inc. develops new medicines built from synergistic combinations of approved drugs. The company develops biopharmaceutical products. It conducts clinical trials and research programs. The company was founded by Alexis Borisy, Brent R. Stockwell, Michael A. Foley, Curtis T. Keith and Jacob D. Goldfield in 2000 and is headquartered in Cambridge, MA | Health Technology |
Genomics Collaborative, Inc.
 Genomics Collaborative, Inc. Medical SpecialtiesHealth Technology Genomics Collaborative, Inc. provides clinical samples and applies human genetics to target validation for drug discovery. The company is based in Cambridge, MA. The company was founded by Phyllis I. Gardner and Edward E. Harlow. Genomics Collaborative was acquired by BioServe Biotechnologies Ltd., a SUB of ReproCELL, Inc. from SeraCare Life Sciences, Inc. on May 29, 2007 for $2 million. | Health Technology |
PharmaStem Therapeutics, Inc.
PharmaStem Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology PharmaStem Therapeutics, Inc. develops umbilical cord and placental blood preservation drugs. The company was founded in 1985 and is headquartered in Larchmont, NY. | Health Technology |
Devon Park Bioventures
Devon Park Bioventures Investment ManagersFinance Devon Park Bioventures (Devon Park Bioventures) is a venture capital firm founded in 2006. The firm is headquartered in Pennsylvania, United States. | Finance |
| Devon Park Associates LLC | |
Vascular Magnetics, Inc.
Vascular Magnetics, Inc. Medical DistributorsDistribution Services Vascular Magnetics, Inc. develops novel therapeutic products. Its VMI contains a magnetic targeting catheter, an apparatus that generates a uniform magnetic field around the leg, and biodegradable magnetic particles that contain a drug that blocks re-obstruction of the artery. The company was founded by Richard S. Woodward and Robert J. Levy in 2010 and is headquartered in Philadelphia, PA. | Distribution Services |
